FDA approves Johnson & Johnson's Varipulse for targeted atrial fibrillation treatment, enhancing precision and safety ...
Johnson & Johnson MedTech will enter the U.S. pulsed field ablation market following an FDA green light for its Varipulse ...
VA physicians can now access the solutions through federal supply Schedule and Defense Logistics Agency ECAT Contract System . MOUNTAIN VIEW, Calif., Nov. 7, ...
The U.S. Food & Drug Administration has approved Johnson & Johnson's device for a type of condition which causes abnormal ...
Boston Scientific ( (BSX) ) just unveiled an announcement. Boston Scientific Corporation has announced the resumption of its AVANT GUARD ...
J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.
Elevated baseline resting heart rate (RHR) is associated with an increased risk for incident atrial fibrillation (AF) ...
Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.
The rapidly growing aging population is driving expansion in healthcare, with rising demand for treatments and chronic disease management. Companies like AbbVie (ABBV), Medtronic (MDT), and Centene ...
14h
He determined that I had a slight atrial fibrillation and mildly obstructed carotids. Subsequent annual testing has shown ...
Dear F.W.: In general, I recommend against stopping prescription medications without your doctor telling you to, and I hope to help you understand why.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback